ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Start-ups

Novo invests in fungi firms to replace animal products

by Melody M. Bomgardner
November 21, 2020 | APPEARED IN VOLUME 98, ISSUE 45

 

Novo Holdings, the controlling owner of Novo Nordisk and Novozymes, has invested in two start-ups that are using fungi to make animal-free products. It led a first round of funding for The Protein Brewery, a Dutch firm working to scale up production of Fermotein, a fungal protein that can be used in meat alternatives, baked goods, and dairy products. Novo also participated in a $45 million series B funding for MycoWorks, a San Francisco–based developer of luxury leather from the mycelium of reishi mushrooms.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment